Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05956678 · ClinicalTrials.gov registry record · NA
Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 3: Sustainment
A NA study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT05956678: Completed NA study, sponsored by University of California, Berkeley.
NCT05956678 is a NA study that has completed, run by University of California, Berkeley. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05956678, a NA study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
Research on the sustainment of implemented evidence-based psychological treatments in routine practice settings, such as community mental health centers, is limited. The goal of this study is to test sustainment predictors, mechanisms, and outcomes of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) in community mental health centers after implementation efforts have ended. CMHC providers have been trained to deliver a "Standard" or "Adapted" version of TranS-C. Researchers will compare these two groups to evaluate differences--and possible mechanisms--with respect to sustainment outcomes.
Primary Outcome
Assesses providers' continued delivery of TranS-C via three self-report items that are rated on a scale from 0 (not at all) to 4 (to a very great extent) such that higher scores indicate more sustainment.
Interventions
- BEHAVIORAL Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
- BEHAVIORAL Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
What the finished NCT05956678 record still lists
NCT05956678 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) is the first listed.
NCT05956678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05956678 about?
NCT05956678 is a clinical study titled "Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 3: Sustainment". Research on the sustainment of implemented evidence-based psychological treatments in routine practice settings, such as community mental health centers, is limited. The goal of this study is to test sustainment predictors, mechanisms, and outcomes of the Transdiagnostic Intervention for Sleep and C...
What is the current status of trial NCT05956678?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2023-04-01. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT05956678?
The interventions under investigation include: Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) (BEHAVIORAL), Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05956678?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05956678's enrollment target sits among peer trials
130 733rd of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI